PUB - Publikationen an der Universität Bielefeld

Alle markieren

• [55]
  

  2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2988304

  Seifert, R. M., Rauch, M., Klingebiel, R., Boese, L. - M., Greeve, I., Rudwaleit, M., & Schäbitz, W. - R. (2023). Case report: Cerebral amyloid angiopathy-related inflammation in a patient with granulomatosis with polyangiitis. Frontiers in Neurology, 14. https://doi.org/10.3389/fneur.2023.1277843

  PUB | PDF | DOI
   
• [54]
  

  2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2985913

  Rudwaleit, M., Morup, M., Humphries, B., Zannat, N. - E., Willems, D., Taieb, V., & Boonen, A. (2023). Work productivity in patients with axial spondyloarthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review and meta-analysis. RMD Open, 9(4), e003468. https://doi.org/10.1136/rmdopen-2023-003468

  PUB | PDF | DOI | Download (ext.) | WoS | PubMed | Europe PMC
   
• [53]
  

  2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2984077

  Löffler, C., Rudwaleit, M., Lakomek, H. - J., Stammann, C., & Hellmich, B. (2023). Patient-reported-Outcomes bei Vaskulitispatienten in Deutschland – Daten aus dem KOBRA-Qualitätsprojekt. Zeitschrift für Rheumatologie. https://doi.org/10.1007/s00393-023-01437-z

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [52]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987167

  Rudwaleit, M., Brown, M., Van Gaalen, F. A., Haroon, N., Gensler, L. S., Fleurinck, C., Marten, A., et al. (2023). LOW UVEITIS RATES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS TREATED WITH BIMEKIZUMAB: POOLED RESULTS FROM PHASE 2B/3 TRIALS. Annals of the Rheumatic Diseases, 82(Suppl. 1), 614-615. https://doi.org/10.1136/annrheumdis-2023-eular.1702

  PUB | DOI | WoS
   
• [51]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987166

  Rudwaleit, M., Van den Bosch, F., Marzo-Ortega, H., Navarro-Compán, V., Tham, R., Kumke, T., Bauer, L., et al. (2023). AN EXPLORATORY ANALYSIS OF THE POTENTIAL DISCONNECT BETWEEN OBJECTIVE INFLAMMATORY RESPONSE AND CLINICAL RESPONSE FOLLOWING CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS. Annals of the Rheumatic Diseases, 82(Suppl. 1), 624-625. https://doi.org/10.1136/annrheumdis-2023-eular.3141

  PUB | DOI | WoS
   
• [50]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987165

  Baraliakos, X., Machado, P., Bauer, L., Hoepken, B., Kim, M., Kumke, T., Tham, R., et al. (2023). COMPARISON OF ESTABLISHED AND NEW, PRELIMINARY PROPOSED ASAS CUT-OFFS FOR INFLAMMATORY MRI LESIONS IN THE SACROILIAC JOINTS OF AXIAL SPONDYLOARTHRITIS PATIENTS AND IMPLICATIONS FOR RECRUITMENT IN CLINICAL STUDIES. Annals of the Rheumatic Diseases, 82(Suppl. 1), 621-622. https://doi.org/10.1136/annrheumdis-2023-eular.2509

  PUB | DOI | WoS
   
• [49]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987161

  Torgutalp, M., Peng, X., Proft, F., Rodriguez, V. R., Rademacher, J., Protopopov, M., Haibel, H., et al. (2023). FACTORS ASSOCIATED WITH ACHIEVING REMISSION IN PATIENTS WITH EARLY PERIPHERAL SPONDYLOARTHRITIS: 10-YEAR RESULTS FROM THE GERMAN SPONDYLOARTHRITIS INCEPTION COHORT (GESPIC). Annals of the Rheumatic Diseases, 82(Suppl. 1), 37-38. https://doi.org/10.1136/annrheumdis-2023-eular.6056

  PUB | DOI | WoS
   
• [48]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987156

  Schmidt, J. F., Kiltz, U., Stammann, C., Schubert-Haack, J., Strunk, J., Lakomek, H. J., Braun, J., et al. (2023). QUALITY STANDARDS FOR PATIENTS WITH AXSPA - STATUS QUO OF DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF AXSPA PATIENTS IN GERMANY. Annals of the Rheumatic Diseases, 82(Suppl. 1), 1713. https://doi.org/10.1136/annrheumdis-2023-eular.2810

  PUB | DOI | WoS
   
• [47]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2980346

  Röchter, M., Thiesbrummel, S., Marchi, H., Fuchs, C., & Rudwaleit, M. (2023). Changes in diagnosing giant cell arteritis of the temporal artery over a 7.7 year period. Annals of the Rheumatic Diseases, 82(Suppl. 1), 1579. https://doi.org/10.1136/annrheumdis-2023-eular.3866

  PUB | DOI | WoS
   
• [46]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987168

  Baraliakos, X., Ramiro, S., Magrey, M., Rudwaleit, M., Haroon, N., Fleurinck, C., Massow, U., et al. (2023). ACHIEVEMENT OF LOW DISEASE ACTIVITY OVER 52 WEEKS IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS ON BIMEKIZUMAB TREATMENT: RESULTS FROM THE PHASE 3 STUDIES BE MOBILE 1 AND BE MOBILE 2. Annals of the Rheumatic Diseases, 82(Suppl. 1), 875-876. https://doi.org/10.1136/annrheumdis-2023-eular.833

  PUB | DOI | WoS
   
• [45]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987172

  Albrecht, K., Thiele, K., Aringer, M., Callhoff, J., Karberg, K., Krueger, K., Lakomek, J., et al. (2023). IMPLEMENTATION OF QUALITY STANDARDS FOR HEALTH CARE OF PATIENTS WITH RHEUMATOID ARTHRITIS: FIRST RESULTS FROM THE NATIONAL DATABASE OF THE GERMAN COLLABORATIVE ARTHRITIS CENTRES. Annals of the Rheumatic Diseases, 82(Suppl. 1), 868-869. https://doi.org/10.1136/annrheumdis-2023-eular.453

  PUB | DOI | WoS
   
• [44]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987170

  Magrey, M., Deodhar, A., Mease, P. J., Navarro-Compán, V., Ramiro, S., Rudwaleit, M., De la Loge, C., et al. (2023). ACHIEVEMENT OF INCREASINGLY STRINGENT CLINICAL RESPONSE CRITERIA AND LOWER LEVELS OF DISEASE ACTIVITY WAS ASSOCIATED WITH GREATER IMPROVEMENTS IN PHYSICAL FUNCTION AND HRQOL IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS FROM TWO PHASE 3 STUDIES ON BIMEKIZUMAB. Annals of the Rheumatic Diseases, 82(Suppl. 1), 1721. https://doi.org/10.1136/annrheumdis-2023-eular.760

  PUB | DOI | WoS
   
• [43]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987174

  Navarro-Compán, V., Benavent, D., Capelusnik, D., Van der Heijde, D., Landewé, R. B. M., Poddubnyy, D., Van Tubergen, A., et al. (2023). ASAS CONSENSUS DEFINITION OF EARLY AXIAL SPONDYLOARTHRITIS. Annals of the Rheumatic Diseases, 82(Suppl. 1), 35-36. https://doi.org/10.1136/annrheumdis-2023-eular.697

  PUB | DOI | WoS
   
• [42]
  

  2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2986690

  van Gaalen, F. A., & Rudwaleit, M. (2023). Challenges in the diagnosis of axial spondyloarthritis. Best Practice & Research Clinical Rheumatology, 37(3), 101871. https://doi.org/10.1016/j.berh.2023.101871

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [41]
  

  2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2985592

  Braun, J., Rudwaleit, M., & Sieper, J. (2023). Zur Rolle von HLA-B27 in der Pathogenese und Diagnostik der axialen Spondyloarthritis. 50 Jahre nach Entdeckung der starken genetischen Assoziation. Zeitschrift fur Rheumatologie. https://doi.org/10.1007/s00393-023-01460-0

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [40]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2983818

  Baraliakos, X., Ramiro, S., Magrey, M., Rudwaleit, M., Haroon, N., Fleurinck, C., Massow, U., et al. (2023). Achievement of low disease activity over 52 weeks in patients with active axial spondyloarthritis on bimekizumab treatment: Results from the phase 3 studies BE MOBILE 1 and BE MOBILE 2. Abstracts of the Annual meeting of theSwiss Society of Rheumatology, Swiss Medical Weekly, 153, 23S. Basel: EMH Schweizerischer Ärzteverlag. https://doi.org/10.57187/smw.2023.40135

  PUB | DOI | WoS
   
• [39]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2984578

  Baraliakos, X., Ramiro, S., Magrey, M., Rudwaleit, M., Haroon, N., Fleurinck, C., Massow, U., et al. (2023). Achievement of low disease activity over 52 weeks in patients with active axial spondyloarthritis on bimekizumab treatment: Results from the Phase 3 studies BE MOBILE 1 and BE MOBILE 2. Abstract Supplement - 39th Scandinavian Congress of Rheumatology, Scandinavian Journal of Rheumatology , 52, 73-74. Abingdon: Taylor & Francis . https://doi.org/10.1080/03009742.2023.2233371

  PUB | DOI | WoS
   
• [38]
  

  2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2982993

  Rudwaleit, M., Machado, P. M., Taieb, V., de Peyrecave, N., Hoepken, B., & Gensler, L. S. (2023). Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthritis. Therapeutic Advances in Musculoskeletal Disease , 15. https://doi.org/10.1177/1759720X231189079

  PUB | DOI | PubMed | Europe PMC
   
• [37]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2982790

  Zochling, J., Robinson, P. C., Maksymowych, W. P., Gensler, L. S., Rudwaleit, M., Hoepken, B., Bauer, L., et al. (2023). Long-term clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis stratified by baseline MRI and c-reactive protein status. Internal Medicine Journal, 53(Suppl. 1), 25. https://doi.org/10.1111/imj.16057

  PUB | DOI | WoS
   
• [36]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2982783

  Rudwaleit, M., Morup, M., Humphries, B., Zannat, N. E., Willems, D., Taieb, V., & Boonen, A. (2023). Systematic Literature Review and Meta-Analysis of Work Productivity in Patients with Axial Spondyloarthritis Treated with Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs. Value in Health, 26(6 Suppl.), S397. https://doi.org/10.1016/j.jval.2023.03.2218

  PUB | DOI | WoS
   
• [35]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2982796

  Bird, P., Mease, P. J., Deodhar, A., Dougados, M., Dubreuil, M., Magrey, M., Marzo-Ortega, H., et al. (2023). Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies. Internal Medicine Journal, 53(S2), 24-25.

  PUB | WoS
   
• [34]
  

  2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2968910

  Braun, J., Rudwaleit, M., Sieper, J., & Specker, C. (2023). Nachruf der Deutschen Gesellschaft für Rheumatologie (DGRh) auf den Träger der Kussmaul-Medaille der DGRh Prof. Dr. Ernst Feldtkeller. Zeitschrift für Rheumatologie. https://doi.org/10.1007/s00393-023-01330-9

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [33]
  

  2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2968373

  Röchter, M. - H., & Rudwaleit, M. (2023). Phänomen der letzten Wiese. Zeitschrift fur Rheumatologie. https://doi.org/10.1007/s00393-022-01304-3

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [32]
  

  2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2968388

  van der Heijde, D., Deodhar, A., Baraliakos, X., Brown, M. A., Dobashi, H., Dougados, M., Elewaut, D., et al. (2023). Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials. Annals of the Rheumatic Diseases. https://doi.org/10.1136/ard-2022-223595

  PUB | PDF | DOI | Download (ext.) | WoS | PubMed | Europe PMC
   
• [31]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2969537

  Magrey, M., Deodhar, A., Mease, P. J., Navarro-Compan, V., Ramiro, S., Rudwaleit, M., de la Loge, C., et al. (2022). Association of Clinical Response Criteria and Disease Activity Levels With Physical Function and HRQoL in Patients With Active Axial Spondyloarthritis: 16-Week Results From Two Phase 3 Randomised, Placebo-Controlled Studies. ISPOR Europe 2022 Abstracts, Value in Health, 25, S427-S428. New York: Elsevier . https://doi.org/10.1016/j.jval.2022.09.2129

  PUB | DOI | WoS
   
• [30]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968210

  Torgutalp, M., Rios-Rodriguez, V., Dilbaryan, A., Proft, F., Protopopov, M., Verba, M., Rademacher, J., et al. (2022). Treatment with Non-steroidal Anti-inflammatory Drugs Is Associated with Retardation of Radiographic Spinal Progression in Patients with Axial Spondyloarthritis: 10-year Results from the GErman SPondyloarthritis Inception Cohort. In American College of Rheumatology (Ed.), Arthritis & Rheumatology: Vol. 74. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA (pp. 2946-2948). Hoboken: Wiley. https://doi.org/10.1002/art.42355

  PUB | DOI | WoS
   
• [29]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968211

  Baraliakos, X., Machado, P., Bauer, L., Hoepken, B., Kim, M., Kumke, T., Tham, R., et al. (2022). Comparison of Established and New, Preliminarily Proposed ASAS Cut-Offs for Inflammatory MRI Lesions in the Sacroiliac Joints of Axial Spondyloarthritis Patients and Implications for Recruitment in Clinical Studies. In American College of Rheumatology (Ed.), Arthritis & Rheumatology: Vol. 74. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA (pp. 1997-2000). Hoboken: Wiley. https://doi.org/10.1002/art.42355

  PUB | DOI | WoS
   
• [28]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968213

  Brandt-Juergens, J., Rudwaleit, M., Behrens, F., Ritchlin, C., Peterlik, D., Quebe-Fehling, E., Calheiros, R., et al. (2022). Uveitis in Patients with Axial Spondyloarthritis or Psoriatic Arthritis: Baseline Characteristics and Incidence Rates During Secukinumab and Placebo Comparative Phase: A Post Hoc Analysis. In American College of Rheumatology (Ed.), Arthritis & Rheumatology: Vol. 74. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA (pp. 2074-2076). Hoboken: Wiley. https://doi.org/10.1002/art.42355

  PUB | DOI | WoS
   
• [27]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968219

  Deodhar, A., van der Heijde, D., Gensler, L., Xu, H., Gaffney, K., Dobashi, H., Maksymowych, W. P., et al. (2022). Bimekizumab Improves Signs and Symptoms, Including Inflammation, in Patients with Active Non-Radiographic Axial Spondyloarthritis: 24-Week Efficacy & Safety from a Phase 3, Multicenter, Randomized, Placebo Controlled Study. In American College of Rheumatology (Ed.), Arthritis & Rheumatology: Vol. 74. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA (pp. 1101-1105). Hoboken: Wiley. https://doi.org/10.1002/art.42355

  PUB | DOI | WoS
   
• [26]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968220

  Diekhoff, T., Eshed, I., Giraudo, C., Haibel, H., Hermann, K. - G., de Hooge, M., Jans, L., et al. (2022). ASAS Recommendations for Requesting and Reporting Imaging in Patients with Suspected Axial Spondyloarthritis. In American College of Reumatology (Ed.), Arthritis & Rheumatology: Vol. 74. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA (pp. 788-790). Hoboken: Wiley. https://doi.org/10.1002/art.42355

  PUB | DOI | WoS
   
• [25]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968222

  Ramiro, S., Nikiphorou, E., Sepriano, A., Ortolan, A., Webers, C., Baraliakos, X., Landewe, R., et al. (2022). ASAS-EULAR Recommendations for the Management of Axial Spondyloarthritis: 2022 Update. In American College of Rheumatology (Ed.), Arthritis & Rheumatology: Vol. 74. ABSTRACT SUPPLEMENT ACR Convergence 2022 ,November 10–14, 2022, Philadelphia, PA (pp. 1094-1097). Hoboken: Wiley. https://doi.org/10.1002/art.42355

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [24]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968218

  Mease, P. J., Deodhar, A., Dougados, M., Dubreuil, M., Magrey, M., Marzo-Ortega, H., Rudwaleit, M., et al. (2022). Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies. In American College of Rheumatolgy (Ed.), Arthritis & Rheumatology: Vol. 74. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA (pp. 810-813). Hoboken: Wiley. https://doi.org/10.1002/art.42355

  PUB | DOI | WoS
   
• [23]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968217

  Maksymowych, W. P., Ostergaard, M., Baraliakos, X., Machado, P., Pedersen, S. J., Weber, U., Eshed, I., et al. (2022). MRI Spinal Lesions in Patients Without MRI or Radiographic Lesions in the Sacroiliac Joints Typical of Axial Spondyloarthritis. In American College of Rheumatology (Ed.), Arthritis & Rheumatology: Vol. 74. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA (pp. 4490-4492). Hoboken: Wiley. https://doi.org/10.1002/art.42355

  PUB | DOI | WoS
   
• [22]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968216

  Magrey, M., Deodhar, A., Mease, P. J., Navarro-Compan, V., Ramiro, S., Rudwaleit, M., De la Loge, C., et al. (2022). Achieving Increasingly Stringent Clinical Response Criteria & Lower Levels of Disease Activity Is Associated with Greater Improvements in Physical Function & HRQoL in Patients with Active Axial Spondyloarthritis: 16-Week Results from Two Phase 3 Randomized, Placebo-Controlled Studies. In American College of Rheumatology (Ed.), Arthritis & Rheumatology: Vol. 74. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA (pp. 814-816). Hoboken: Wiley. https://doi.org/10.1002/art.42355

  PUB | DOI | WoS
   
• [21]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968215

  Rudwaleit, M., Van den Bosch, F., Marzo-Ortega, H., Navarro-Compan, V., Tham, R., Kumke, T., Bauer, L., et al. (2022). An Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial Spondyloarthritis. In American College of Rheumatology (Ed.), Arthritis & Rheumatology: Vol. 74. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA (pp. 1097-1100). Hoboken: Wiley. https://doi.org/10.1002/art.42355

  PUB | DOI | WoS
   
• [20]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968214

  Robinson, P. C., Maksymowych, W. P., Gensler, L., Rudwaleit, M., Hoepken, B., Bauer, L., Kumke, T., et al. (2022). Long-Term Clinical Outcomes of Certolizumab Pegol Treatment in Patients with Active Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status. In American College of Rheumatology (Ed.), Arthritis & Rheumatology: Vol. 74. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA (pp. 808-810). Hoboken: Wiley. https://doi.org/10.1002/art.42355

  PUB | DOI | WoS
   
• [19]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966738

  Navarro-Compan, V., Rudwaleit, M., De Peyrecave, N., Fleurinck, C., Oortgiesen, M., Taieb, V., & Baraliakos, X. (2022). MAINTENANCE OF RESPONSE TO BIMEKIZUMAB OVER 3 YEARS OF TREATMENT IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: POST HOC ANALYSES FROM THE BE AGILE STUDY AND ITS OPEN-LABEL EXTENSION. Annals of the Rheumatic Diseases, 81(Suppl. 1), 771-772. https://doi.org/10.1136/annrheumdis-2022-eular.2138

  PUB | DOI | WoS
   
• [18]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966741

  Torgutalp, M., Rodriguez, V. R., Dilbaryan, A., Proft, F., Protopopov, M., Verba, M., Rademacher, J., et al. (2022). TREATMENT WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IS ASSOCIATED WITH RETARDATION OF RADIOGRAPHIC SPINAL PROGRESSION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: 10-YEAR RESULTS FROM THE GERMAN SPONDYLOARTHRITIS INCEPTION COHORT. Annals of the Rheumatic Diseases, 81, 14-15. London: Bmj Publishing Group. https://doi.org/10.1136/annrheumdis-2022-eular.4337

  PUB | DOI | WoS
   
• [17]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966746

  Robinson, P., Maksymowych, W. P., Gensler, L. S., Rudwaleit, M., Hoepken, B., Bauer, L., Kumke, T., et al. (2022). LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS. Annals of the Rheumatic Diseases, 81, 774-775. London: Bmj Publishing Group. https://doi.org/10.1136/annrheumdis-2022-eular.2834

  PUB | DOI | WoS
   
• [16]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966748

  Deodhar, A., Van der Heijde, D., Gensler, L. S., Xu, H., Gaffney, K., Dobashi, H., Maksymowych, W. P., et al. (2022). BIMEKIZUMAB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 1, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY. Annals of the Rheumatic Diseases, 81, 772-773. London: Bmj Publishing Group. https://doi.org/10.1136/annrheumdis-2022-eular.2416

  PUB | DOI | WoS
   
• [15]
  

  2022 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2965259

  Torgutalp, M., Rodriguez, V. R., Proft, F., Protopopov, M., Verba, M., Rademacher, J., Haibel, H., et al. (2022). Treatment With Tumor Necrosis Factor Inhibitors Is Associated With a Time-Shifted Retardation of Radiographic Sacroiliitis Progression in Patients With Axial Spondyloarthritis: 10-Year Results From the German Spondyloarthritis Inception Cohort. Arthritis & Rheumatology . https://doi.org/10.1002/art.42144

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [14]
  

  2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2963951

  Torgutalp, M., Rios Rodriguez, V., Dilbaryan, A., Proft, F., Protopopov, M., Verba, M., Rademacher, J., et al. (2022). Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis. Annals of the rheumatic diseases, 81(9), 1252-1259. https://doi.org/10.1136/annrheumdis-2022-222324

  PUB | PDF | DOI | Download (ext.) | WoS | PubMed | Europe PMC
   
• [13]
  

  2022 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2964357

  Robinson, P. C., Maksymowych, W. P., Gensler, L. S., Hall, S., Rudwaleit, M., Hoepken, B., Bauer, L., et al. (2022). Certolizumab Pegol Efficacy in Patients With Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status: An Analysis From the C-axSpAnd Study. ACR Open Rheumatology. https://doi.org/10.1002/acr2.11469

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [12]
  

  2022 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2963700

  Baraliakos, X., Ostergaard, M., Lambert, R. G., Eshed, I., Machado, P. M., Pedersen, S. J., Weber, U., et al. (2022). MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working group. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2021-222081

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [11]
  

  2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2962214

  van der Heijde, D., Gensler, L. S., Maksymowych, W. P., Landewe, R., Rudwaleit, M., Bauer, L., Kumke, T., et al. (2022). Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study. RMD Open, 8(1), e002138. https://doi.org/10.1136/rmdopen-2021-002138

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [10]
  

  2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961894

  Baraliakos, X., Rodriguez, V. R., Torgutalp, M., Dilbaryan, A., Haibel, H., Verba, M., Sieper, J., et al. (2021). Structural Damage in Axial Spondyloarthritis: Is There a Preferred Way to Assess Progression over Time? In American College of Rheumatology (Ed.), Arthritis & Rheumatology : Vol. 73. Abstract Supplement ACR Convergence 2021 (pp. 319-321). Hoboken: Wiley. https://doi.org/10.1002/art.41966

  PUB | DOI | WoS
   
• [9]
  

  2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961900

  Maksymowych, W., Lambert, R., Baraliakos, X., Pedersen, S., Eshed, I., Weber, U., Machado, P., et al. (2021). Data-driven Definitions Based on Inflammatory Lesions for a Positive MRI of the Spine Consistent with Axial Spondyloarthritis. In American College of Rheumatology (Ed.), Arthritis & Rheumatology: Vol. 73. Abstract Supplement ACR Convergence 2021 (pp. 1878-1880). Hoboken: Wiley. https://doi.org/10.1002/art.41966

  PUB | DOI | WoS
   
• [8]
  

  2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961899

  Maksymowych, W., Weber, U., Baraliakos, X., Machado, P., Pedersen, S., Sieper, J., Wichuk, S., et al. (2021). Scoring MRI Structural Lesions in Sacroiliac Joints of Patients with Axial Spondyloarthritis: How Many Slices Are Optimal? In American College of Rheumatology (Ed.), Arthritis & Rheumatology: Vol. 73. Abstract Supplement ACR Convergence 2021 (pp. 1876-1878). Hoboken: Wiley. https://doi.org/10.1002/art.41966

  PUB | DOI | WoS
   
• [7]
  

  2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961897

  van der Heijde, D., Gensler, L., Maksymowych, W., Landewe, R., Rudwaleit, M., Bauer, L., Hoepken, B., et al. (2021). Long-Term Safety and Efficacy of Certolizumab Pegol in Patients with Active Non-Radiographic Axial Spondyloarthritis: 3-Year Results from a Phase 3 Multicenter Study. In American College of Rheumatology (Ed.), Arthritis & Rheumatology: Vol. 73. Abstract Supplement ACR Convergence 2021 (pp. 1896-1899). Hoboken: Wiley. https://doi.org/10.1002/art.41966

  PUB | DOI | WoS
   
• [6]
  

  2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961896

  Magrey, M., Ramiro, S. A., Pinheiro, M. M., Gao, T., Ganz, F., Song, I. - H., Biljan, A., et al. (2021). Predictors of 1-Year Treatment Response Among Upadacitinib-Treated Patients with Ankylosing Spondylitis: A Post Hoc Analysis. In American College of Rheumatology (Ed.), Arthritis & Rheumatology : Vol. 73. Abstract Supplement ACR Convergence 2021 (pp. 1931-1933). Hoboken: Wiley. https://doi.org/10.1002/art.41966

  PUB | DOI | WoS
   
• [5]
  

  2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961895

  Rudwaleit, M., Machado, P., Gensler, L., Taieb, V., de Peyrecave, N., Hoepken, B., & van der Heijde, D. (2021). Achievement of Stringent Thresholds of Disease Control Is Associated with Reduced Burden on Work and Household Productivity in Patients with Axial Spondyloarthritis. In American College of Rheumatology (Ed.), Arthritis & Rheumatology : Vol. 73. Abstract Supplement ACR Convergence 2021 (pp. 734-738). Hoboken: Wiley. https://doi.org/10.1002/art.41966

  PUB | DOI | WoS
   
• [4]
  

  2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961892

  Torgutalp, M., Rodriguez, V. R., Verba, M., Protopopov, M., Proft, F., Rademacher, J., Haibel, H., et al. (2021). Tumor Necrosis Factor Inhibitors Show a Delayed Effect on Radiographic Sacroiliitis Progression in Patients with Early Axial Spondyloarthritis: 10-Year Results from the German Spondyloarthritis Inception Cohort. In American College of Rheumatology (Ed.), Arthritis & Rheumatology : Vol. 73. Abstract Supplement ACR Convergence 2021 (pp. 931-933). Hoboken: Wiley. https://doi.org/10.1002/art.41966

  PUB | DOI | WoS
   
• [3]
  

  2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961881

  Kristensen, L. E., McGonagle, D., Rudwaleit, M., Kameda, H., Holzkaemper, T., El Baou, C., & Smolen, J. (2021). Association of the improvement of Synovitis and Enthesitis with quality of life/patient reported outcomes in patients with PsA treated with Ixekizumab. In American College of Rheumatology (Ed.), Arthritis & Rheumatology : Vol. 73. Abstract Supplement ACR Convergence 2021 (pp. 3722-3724). Hoboken: Wiley. https://doi.org/10.1002/art.41966

  PUB | DOI | WoS
   
• [2]
  

  2021 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2959486

  Maksymowych, W. P., Kumke, T., Auteri, S. E., Hoepken, B., Bauer, L., & Rudwaleit, M. (2021). Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol. Arthritis Research and Therapy , 23(1), 274. https://doi.org/10.1186/s13075-021-02650-4

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [1]
  

  2021 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2958359

  Kiltz, U., Buschhorn-Milberger, V., Albrecht, K., Lakomek, H. - J., Lorenz, H. - M., Rudwaleit, M., Schneider, M., et al. (2021). Entwicklung von Qualitätsstandards für die Versorgung von Patient*innen mit rheumatoider Arthritis zur Anwendung in Deutschland. Zeitschrift fur Rheumatologie. https://doi.org/10.1007/s00393-021-01093-1

  PUB | DOI | WoS | PubMed | Europe PMC